Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Comparison of Blood Dopamine Levels in Idiopathic Parkinson's Patients Receiving Levodopa Carbidopa Entacapone or Levodopa Benserazide

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06115538
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:26.974411+00:00
Published At
2023-11-28T00:00:00+00:00
Record Updated At
2023-11-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Parkinson Disease", "Treatment Adherence"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-11-28"
protocolSection.identificationModule.nctId
"NCT06115538"
protocolSection.identificationModule.officialTitle
"Comparison of Blood Dopamine Levels in Idiopathic Parkinson\u0027s Patients Receiving Levodopa Carbidopa Entacapone or Levodopa Benserazide"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Parkinson Disease (protocolSection.conditionsModule.conditions)
  • Treatment Adherence (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.